Insights

Tax tips, options trading ideas, and market takes — updated regularly.

filtered by tagclear

Options Strategies Market Commentary
No Shareholder Vote Required: What argenx's $77-a-Share Tender Offer for Forte Biosciences Teaches About How Deals Close

argenx is buying Forte Biosciences through a cash tender offer, not a traditional merger vote — a structure that closes faster and prices differently in the merger-arbitrage market. Here's how to tell the two apart.

August 9, 2026 ET